Beta3-adrenoceptors: relaxant function and mRNA detection in smooth muscle cells isolated from the human colon

Canadian Journal of Physiology and Pharmacology
Carola SeveriGianfranco Delle Fave

Abstract

Functional involvement of beta3-adrenoceptors in controlling human gastrointestinal motility has not been unequivocally assessed yet. The direct myogenic contribution of these receptors was examined, by in vitro functional studies and analysis of mRNA expression, on smooth muscle cells separately isolated from taenia coli and circular muscle layers of the human colon. Isoproterenol, a nonselective beta-adrenoceptor agonist, relaxed, in a concentration-dependent manner, both human taenia coli and circular colonic smooth muscle cells, although displaying a higher intrinsic activity (65.3 +/- 2.3 vs. 55.2 +/- 1.4% maximal relaxation) and potency (pEC50: 7.41 +/- 0.07 vs. 6.32 +/- 0.08) were greater on taenia coli than circular cells. In the presence of the beta1-antagonist CGP20712A and of the beta2-antagonist ICI 118,551, a 25-30% decrease in isoproterenol intrinsic activity was observed on both cell types and on taenia coli, the nonselective beta1/beta2-antagonist propranolol produced a rightward shift of the isoproterenol concentration-response curve with mean estimated pKB values (8.12 +/- 0.27 at 0.1 microM and 6.45 +/- 0.13 at 1 microM) lower than that expected for both beta1- and beta2-adrenoceptors. CGP12177A and SR 58611A...Continue Reading

References

Mar 1, 1991·Biochemical Pharmacology·L J EmorineD A Strosberg
Apr 1, 1991·Scandinavian Journal of Gastroenterology·S LindgrenG Sundkvist
Jan 1, 1985·Scandinavian Journal of Gastroenterology. Supplement·E Lyrenäs
Mar 1, 1987·Scandinavian Journal of Gastroenterology·B HallerbäckK Kirnö
May 1, 1995·The Journal of Pharmacy and Pharmacology·J McKean, A MacDonald
Apr 28, 1995·European Journal of Pharmacology·D E BerkowitzD A Schwinn
Jan 1, 1993·The Journal of Clinical Investigation·S KriefL J Emorine
Jan 1, 1995·Fundamental & Clinical Pharmacology·L ManaraM Landi
Jul 11, 1996·European Journal of Pharmacology·E J LezamaD R Feller
Apr 1, 1997·British Journal of Pharmacology·S J RobertsR J Summers
Nov 22, 1997·European Journal of Pharmacology·K KoikeT Nagatomo
Jul 25, 1998·Alimentary Pharmacology & Therapeutics·A AnthonyA J Wakefield
May 18, 1999·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·F de PontiG Frigo
Apr 25, 2003·Canadian Journal of Physiology and Pharmacology·Catherine Lavoie, Terence E Hébert
Sep 1, 1964·International Journal of Neuropharmacology·K A NORBERG

❮ Previous
Next ❯

Citations

Jun 11, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Marco SenzoloAndrew Kenneth Burroughs
Oct 17, 2006·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·C SeveriG Delle Fave
Feb 21, 2006·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·V D CorletoG Delle Fave
Feb 15, 2019·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Alicia HanmanJan D Huizinga

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.